one-year weight reduction with semaglutide or liraglutide in clinical practice Study of 3389 patients obesity practice: the mean 1-year year loss was −5.1% for #semaglutide vs −2.2% for #liraglutide. Factors positively associated with achieving at least 10% weight Semaglutide as a GLP-1 Agonist:

These include semaglutide (marketed as Ozempic and Wegovy ), tirzepatide (marketed as Mounjaro and Zepbound ), and the investigational triple agonist retatrutide

Important Precautions Before and During Use 14.1 Regular Monitoring of Blood Glucose Levels Keeping a close eye on blood sugar levels is crucial for making sure treatments are working and are safe

Extends Growth Phase: Helps follicles stay in the active growth phase longer, which can result in thicker and longer hair over time

This trial the highest dose of retatrutide (12 mg) led to 16.9% weight loss (vs 3.0% with placebo) at 36 weeks

It means using food and habits that match how the gut lining actually heals